The Department of Health offers this:
The review will be led by National Clinical Director for Pathology Dr Ian Barnes and will scrutinise NHS arrangements for the oversight and safeguards of laboratory testing. Pathology tests are often needed to diagnose and establish the best way to treat chronic or life threatening conditions and to monitor patients’ progress whilst they receive treatment.
The review will bring together experts in the field to explore how Quality Assurance systems can be strengthened and how organisations can be more confident about the monitoring of the quality of care they offer the public. The Review will make recommendations for the NHS Commissioning Board to consider.
“Every patient should receive the best care possible. The NHS has a strong reputation for providing high-grade laboratory tests. With advances in technology and practice, I want to ensure that quality remains at the forefront.”
Around two million pathology tests are carried out by the NHS every day, and serious incidents are rare. However, concerns were raised at Sherwood Forest NHS Foundation Trust in October about pathology testing of breast cancers, used to choose the best treatment for each patient, where the care of a small number of women was disadvantaged.
“This is important work which will help to assure the processes that govern laboratory testing are as strong as they can be. The UKhas an enviable reputation for its pathology services and I look forward to making recommendations as to how the NHS can maintain and better this.”
Note to readers
Tell the review we don’t need more of CPA and UKAS. The cartel is not the source of quality or value for patients. Its bureaucracy should be out. Efficiency and value should be in.